178 related articles for article (PubMed ID: 8137453)
1. Effect of gastrectomy on the pharmacokinetics of tegafur, uracil, and 5-fluorouracil after oral administration of a 1:4 tegafur and uracil combination.
Maehara Y; Takeuchi H; Oshiro T; Takahashi I; Inutsuka S; Baba H; Kohnoe S; Sugimachi K
Cancer Chemother Pharmacol; 1994; 33(6):445-9. PubMed ID: 8137453
[TBL] [Abstract][Full Text] [Related]
2. [Blood concentrations of futraful, uracil and 5-fluorouracil (5-FU) after UFT administration in the various reconstructions after gastrectomy. Saitama UFT Research Group].
Suda Y; Uchida K; Okamura H; Oshima Y; Shimizu M; Miyakawa T; Okubo S; Shiina E; Hosoda Y; Tokura Y
Gan To Kagaku Ryoho; 1992 Nov; 19(13):2181-7. PubMed ID: 1444484
[TBL] [Abstract][Full Text] [Related]
3. [A study of urinary tegafur, 5-fluorouracil (5-FU) and uracil concentrations in the cases of gastric carcinoma for the confirmation of drug-taking compliance after UFT oral administration].
Ohsawa S; Kondo Y; Shiroto H; Masuko H; Fukushima T; Kataoka A; Ohmori K; Sawaguchi Y; Baba E; Takahashi T
Gan To Kagaku Ryoho; 1992 Nov; 19(13):2189-93. PubMed ID: 1444485
[TBL] [Abstract][Full Text] [Related]
4. Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.
Ho DH; Pazdur R; Covington W; Brown N; Huo YY; Lassere Y; Kuritani J
Clin Cancer Res; 1998 Sep; 4(9):2085-8. PubMed ID: 9748123
[TBL] [Abstract][Full Text] [Related]
5. A pharmacodynamic and pharmacokinetic study of fluoropyrimidines in a nude mouse system and in postoperative patients with gastric cancer.
Inada T; Ogata Y; Kubota T; Ozawa I; Hishinuma S; Shimizu H; Kotake K; Ikeda T; Koyama Y
Surg Today; 1993; 23(8):687-92. PubMed ID: 8400672
[TBL] [Abstract][Full Text] [Related]
6. A clinical pharmacokinetic analysis of tegafur-uracil (UFT) plus leucovorin given in a new twice-daily oral administration schedule.
Etienne-Grimaldi MC; François E; Cardot JM; Renée N; Douillard JY; Gamelin E; Bennouna J; Château Y; Milano G
Clin Pharmacokinet; 2007; 46(11):953-63. PubMed ID: 17922560
[TBL] [Abstract][Full Text] [Related]
7. [The serum and tissue concentrations of tegafur, 5-fluorouracil and uracil in patients with gastric and colorectal cancers after oral administration of UFT].
Takahashi N; Nitta A; Saitou T; Mori Y; Kunii Y; Kikuchi K
Gan To Kagaku Ryoho; 1988 Aug; 15(8):2319-23. PubMed ID: 3136701
[TBL] [Abstract][Full Text] [Related]
8. Effect of food on the oral bioavailability of UFT and leucovorin in cancer patients.
Damle B; Ravandi F; Kaul S; Sonnichsen D; Ferreira I; Brooks D; Stewart D; Alberts D; Pazdur R
Clin Cancer Res; 2001 Mar; 7(3):517-23. PubMed ID: 11297242
[TBL] [Abstract][Full Text] [Related]
9. [Long-term administration of tegafur in postoperative adjuvant chemotherapy in gastric cancer patients. Serial analysis of serum tegafur and 5-fluorouracil concentrations, and influence from PSK combination].
Tanaka T; Kitao T; Furutani M; Harada T; Hayashi S; Matsushita T; Asada I; Shirosaki H
Gan To Kagaku Ryoho; 1989 Jan; 16(1):95-9. PubMed ID: 2492184
[TBL] [Abstract][Full Text] [Related]
10. [Study on the concentrations of 5-fluorouracil (5-FU), tegafur (ET) and uracil in bile: comparison of UFT or FT].
Tomita T; Tajima T; Ishibashi M; Tagaya N; Aoki H; Itoh S; Kadowaki A; Kogure H; Tajima Y
Gan To Kagaku Ryoho; 1989 Dec; 16(12):3755-62. PubMed ID: 2512859
[TBL] [Abstract][Full Text] [Related]
11. [Studies on 5-FU concentration in serum and prostate cancer tissue after oral administration of UFT].
Shinoda I; Takahashi Y; Takeuchi T; Kuriyama M; Ban Y; Kawada Y; Ito Y; Yamamoto N; Maeda S; Tada K
Hinyokika Kiyo; 1991 Jul; 37(7):711-5. PubMed ID: 1927771
[TBL] [Abstract][Full Text] [Related]
12. Modelling of ftorafur and 5-fluorouracil pharmacokinetics following oral UFT administration. A population study in 30 patients with advanced breast cancer.
Urien S; Fumoleau P; Campone M; Kerbrat P; Bonneterre J; Fargeot P; Deporte-Fety R
Cancer Chemother Pharmacol; 2003 Aug; 52(2):99-107. PubMed ID: 12768319
[TBL] [Abstract][Full Text] [Related]
13. [Blood and tumor levels of tegafur, 5-fluorouracil, and uracil].
Takeshita T; Iwasaki M; Narita M; Sou M; Sato M; Hashimoto T; Kameya S; Iigima N
Gan To Kagaku Ryoho; 1988 Nov; 15(11):3053-8. PubMed ID: 3142365
[TBL] [Abstract][Full Text] [Related]
14. [Concentration of 5-fluorouracil in the blood and tissues of gastric and colo-rectal cancer patients after oral administration of UFT].
Inaba S; Kondo Y; Tsuchiya K; Kawai K; Ogino A; Umeda T; Ueda Y
Gan To Kagaku Ryoho; 1992 Nov; 19(13):2175-80. PubMed ID: 1444483
[TBL] [Abstract][Full Text] [Related]
15. Tegafur/uracil + calcium folinate in colorectal cancer: double modulation of fluorouracil.
Hoff PM; Lassere Y; Pazdur R
Drugs; 1999; 58 Suppl 3():77-83. PubMed ID: 10711845
[TBL] [Abstract][Full Text] [Related]
16. Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: a randomised crossover trial in advanced colorectal cancer.
Borner MM; Schoffski P; de Wit R; Caponigro F; Comella G; Sulkes A; Greim G; Peters GJ; van der Born K; Wanders J; de Boer RF; Martin C; Fumoleau P
Eur J Cancer; 2002 Feb; 38(3):349-58. PubMed ID: 11818199
[TBL] [Abstract][Full Text] [Related]
17. [Pre- and post-operative adjuvant chemotherapy of colorectal cancer. Part 1. Drug concentration in tissues following UFT administration].
Tomita M; Shimoyama T; Hirano T; Nakagoe T; Shimizu T; Kusano H; Fukuda Y; Eida K; Ishii T; Kotake Y
Gan To Kagaku Ryoho; 1988 Dec; 15(12):3239-43. PubMed ID: 3143310
[TBL] [Abstract][Full Text] [Related]
18. UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancer.
Hoff PM; Pazdur R; Benner SE; Canetta R
Anticancer Drugs; 1998 Jul; 9(6):479-90. PubMed ID: 9877235
[TBL] [Abstract][Full Text] [Related]
19. Anticancer drug distribution in lymph and blood during adjuvant chemotherapy after surgery for gastric carcinoma. A study with a combined preparation of 1-(2-tetrahydrofuryl)-5-fluorouracil and uracil.
Hanaue H; Kurosawa T; Kitano Y; Miyakawa S; Nemoto A; Yamamoto H; Asagoe T; Takada T; Yasuda H; Shikata J
Cancer; 1987 May; 59(9):1571-6. PubMed ID: 3103905
[TBL] [Abstract][Full Text] [Related]
20. Alternative pharmacokinetics of S-1 components, 5-fluorouracil, dihydrofluorouracil and alpha-fluoro-beta-alanine after oral administration of S-1 following total gastrectomy.
Kim WY; Nakata B; Hirakawa K
Cancer Sci; 2007 Oct; 98(10):1604-8. PubMed ID: 17683513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
